Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway

Shuangyu Li, Renqing Wang, Tong Wang, Wenyan Zhang, Shengchun Xu, Zhenhua Ren, Renfei Luo

Open source

DOI
10.3389/fphar.2026.1865261
Published
2026-09-07
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1865261,
  title = {Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway},
  author = {Shuangyu Li and Renqing Wang and Tong Wang and Wenyan Zhang and Shengchun Xu and Zhenhua Ren and Renfei Luo},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1865261},
  url = {https://doi.org/10.3389/fphar.2026.1865261}
}

RIS

TY  - JOUR
TI  - Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway
AU  - Shuangyu Li
AU  - Renqing Wang
AU  - Tong Wang
AU  - Wenyan Zhang
AU  - Shengchun Xu
AU  - Zhenhua Ren
AU  - Renfei Luo
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1865261
UR  - https://doi.org/10.3389/fphar.2026.1865261
ER  - 

APA

Li, S., Wang, R., Wang, T., Zhang, W., Xu, S., Ren, Z., & Luo, R. (2026). Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1865261

Source records